IL-8 levels above the median were also associated with an increased risk of AV access complications and remained independently predictive of the risk after adjustment for MCP-1 levels, demographics, vascular access type, diabetes history, and body mass index. This evidence concerns the gene CCL2 and diabetes mellitus.